CRISPR-based gene editing techniques have been developed and refined over the last decade. They are now routinely used in laboratories to manipulate and edit genes to better understand disease processes. But are CRISPR-based techniques ready for use in humans? What needs to be done before as a society we are comfortable engineering the DNA of future generations.
Genetic epilepsies and developmental and epileptic encephalopathies (DEEs) significant impact the quality of life of patients.